115 filings
Page 4 of 6
6-K
v0a8r45ph630kpopmwm
12 Oct 10
Current report (foreign)
12:00am
6-K
5j9aipv7 htnt2rgt
7 Sep 10
3SBio and Isotechnika Pharma Announce Strategic Partnership
12:00am
6-K
jew0fy63zflh5hhy8rhk
25 Aug 10
Current report (foreign)
12:00am
6-K
g46d9m0u1oea1fo6rduv
24 May 10
Current report (foreign)
12:00am
6-K
fyap3uocuju7mdde
23 Mar 10
3SBio Announces Changes to its Board of Directors
12:00am
6-K
2ji2gglungsa 5i3l
23 Feb 10
Current report (foreign)
12:00am
6-K
76tw8b
23 Feb 10
Current report (foreign)
12:00am
6-K
r8e0rcfv9p7s
23 Feb 10
3SBio and Ascentage Pharma Form Strategic Alliance to Research, Develop and Commercialize Cancer Therapeutics
12:00am
6-K
1cv12s25ilon4xk5y
11 Feb 10
3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxilfor Hyperphosphatemia
12:00am
6-K
m66 x8j34qdxro30t9
11 Jan 10
Form 6-K for Feraheme Registration Trial Application
12:00am
6-K
q7r534d
13 Nov 09
Current report (foreign)
12:00am
6-K
q6tmr
22 Oct 09
3SBio Inc. Announces Results of Annual General Meeting
12:00am
6-K
opcabu63pjvi7tn0pl
14 Sep 09
Current report (foreign)
12:00am
6-K
1t6mcgph0hceh
14 Aug 09
Current report (foreign)
12:00am
CT ORDER
3sr5koxu
30 Jun 09
Confidential treatment order
12:00am
CT ORDER
zc951kw3hs lbh
30 Jun 09
Confidential treatment order
12:00am
6-K
sd3 3ixu5e
28 May 09
Current report (foreign)
12:00am
6-K
7mwcwol6q 37n0iva4
21 May 09
Current report (foreign)
12:00am
20-F/A
eu9lovuj g2o
15 May 09
Annual report (foreign) (amended)
12:00am